In last week's post we wrote about the need for both managed care and pharmaceutical manufacturers to engage in conversation around ways to make pre-approval drug evidence more readily available, and more importantly, actionable. The AMCP Managed Care & Specialty Pharmacy Annual Meeting, taking place at the Moscone West in San Francisco this week is the perfect opportunity to make this happen. 

During the conference Advera Health will be actively working to discuss evidence acquisition and generation pre- and post-approval, both at our exhibit hall booth, #539 and at our poster presentation (T02).

We encourage both healthcare decision makers from managed care and manufacturer representatives to come by and learn more. 

Keith Hoffman, VP of Scientific Affairs will be presenting his poster (T02), Predicting FDA Alerts on Thursday, April 21st from 11:45a - 2:45p PDT and then again on Friday, April 22nd from 9:30a - 11:00a. 

Andrew Stadvec, Senior Business Development Manager will be at booth #539 during Exhibition Hours. 

If you would like to schedule 1-1 time with either Andrew or Keith, please contact us requesting a meeting.  

Brian Overstreet, CEO

Brian-2.png

Topics: Managed Care

Brian Overstreet

Written by Brian Overstreet